Relay Therapeutics, Inc. has grown revenue 122% a year over three years and −29% a year over five. Revenue growth, 3-year annual rate: +122% (Biotechnology median +21%). Revenue growth, 5-year rate: −29%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

RLAYRelay Therapeutics, Inc.

HealthcareUSD

$19.45

$3.2252 weeks$20.77

Is it growing?

Is RLAY growing?

Relay Therapeutics, Inc. has grown revenue 122% a year over three years and −29% a year over five.

+122%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −29%
Revenue growth, 5-year rate · +122% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›